 announced it has been awarded a contract with the

, to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medication in humans.

This award is a five year contract with a ceiling value of $9,695,476 beginning September 2012.  Vince and Associates will conduct clinical pharmacology studies to support the development of new medications for the treatment of substance abuse disorders.

“Our organization will research investigational medications to include new chemical entities, new biological products such as monoclonal antibodies, enzymes and vaccines as well as already approved drug products,” said 

, president and medical director of Vince & Associates Clinical Research.  “Our organization is excited to work on clinical studies with NIDA that may benefit those struggling with substance abuse disorders.”
